Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2026-01-04 @ 4:40 AM
Study NCT ID:
NCT06244368
Status:
RECRUITING
Last Update Posted:
2025-05-14
First Post:
2024-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT2023065
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |
| None | OTHER | View |
| None | UNKNOWN | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |
| None | OTHER | View |